Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New urine test could improve bladder cancer diagnosis

NCT ID NCT06072027

First seen Mar 19, 2026 · Last updated Jun 16, 2026 · Updated 17 times

Summary

This study tested a new urine test called VISIOCYT to see how well it finds bladder tumors compared to standard methods. About 700 adults with suspected or follow-up bladder cancer provided urine samples before their regular cystoscopy. The goal was to measure the test's accuracy in detecting cancer, which could help reduce the need for invasive procedures in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Institut Paoli-Calmettes

    Marseille, 13009, France

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.